FAM
KRTX

Fred Alger Management’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History

Fred Alger Management’s Portfolio KRTX Stock Details KRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-21,776
Closed -$6.89M – 504
2023
Q4 		$6.89M Sell
21,776
-3,930
-15% -$764K 0.04% 217
2023
Q3 		$4.35M Sell
25,706
-6
-0% -$1.13K 0.03% 250
2023
Q2 		$5.58M Sell
25,712
-656
-2% -$141K 0.03% 241
2023
Q1 		$4.79M Buy
26,368
+4
+0% +$765 0.03% 258
2022
Q4 		$5.18M Buy
26,364
+8
+0% +$1.72K 0.03% 259
2022
Q3 		$5.93M Sell
26,356
-1,318
-5% -$267K 0.03% 245
2022
Q2 		$3.5M Buy
27,674
+791
+3% +$90.9K 0.02% 293
2022
Q1 		$3.41M Sell
26,883
-160
-0.6% -$18K 0.01% 304
2021
Q4 		$3.54M Sell
27,043
-982
-4% -$127K 0.01% 324
2021
Q3 		$3.43M Buy
28,025
+409
+1% +$47.2K 0.01% 314
2021
Q2 		$3.15M Sell
27,616
-14,623
-35% -$1.71M 0.01% 331
2021
Q1 		$5.08M Buy
+42,239
New +$4.79M 0.01% 297
2020
Q3 		– Sell
-8,000
Closed -$892K – 525
2020
Q2 		$892K Buy
+8,000
New +$696K ﹤0.01% 364

Other funds holding KRTX

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
S
Sachetta Lynnfield, Massachusetts $206M AUM 26.19% 1-Year Est. Return

Fred Alger Management's KRTX Position: Q1 2024 in Review

Fred Alger Management sold out of Karuna Therapeutics, Inc. Common Stock (KRTX) in Q1 2024, closing a stake of 21,776 shares — an estimated $6.89M sold.

Fred Alger Management first reported a position in KRTX in Q2 2020 and held it in 13 quarters. The position peaked at $6.89M in Q4 2023. 2 funds tracked by Wall St. Rank hold KRTX as of Q1 2024.

  • Fred Alger Management reported no remaining Karuna Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Fred Alger Management sold 21,776 Karuna Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $6.89M.
  • Fred Alger Management first reported a position in Karuna Therapeutics, Inc. Common Stock in Q2 2020 and held it in 13 quarters.
  • Fred Alger Management's Karuna Therapeutics, Inc. Common Stock position peaked at $6.89M in Q4 2023.
  • 2 funds tracked by Wall St. Rank held Karuna Therapeutics, Inc. Common Stock as of Q1 2024.

Based on Fred Alger Management's 13F filing for Q1 2024, filed 15 May 2024.